Latest news
Midday Need to Know: Payrolls fall, Lilly and Novo win antitrust battle & more (SPY:NYSEARCA) - Seeking AlphaSeeking Alpha · Fri, 07 Aug 2026 16:03:11 GMTNovo Nordisk: Dismal Q2 Earnings, Operational Frailties Warrant Rating Downgrade (NVO) - Seeking AlphaSeeking Alpha · Fri, 07 Aug 2026 14:55:18 GMTNovo Nordisk: The Market Has Lost Its Mind, Too Cheap To Ignore (NYSE:NVO) - Seeking AlphaSeeking Alpha · Thu, 06 Aug 2026 16:33:21 GMTLilly outperforms in bid to unseat Novo’s lead in oral GLP-1 market - Seeking AlphaSeeking Alpha · Wed, 05 Aug 2026 18:48:44 GMTNovo Nordisk slips despite lifting guidance on GLP-1 strength (NVO:NYSE) - Seeking AlphaSeeking Alpha · Tue, 04 Aug 2026 17:16:55 GMTNovo Nordisk drops as anti-inflammatory drug fails in late-stage trial - Seeking AlphaSeeking Alpha · Fri, 31 Jul 2026 07:00:00 GMT